Related Experiment Videos
Macrolide antibiotics and asthma treatment
1Department of Respiratory Medicine, National Heart and Lung Institute, and the Wright Fleming Institute of Infection and Immunity, Imperial College London. s.johnston@imperial.ac.uk
The Journal of Allergy and Clinical Immunology
|June 6, 2006
Summary
Atypical bacterial infections may worsen asthma exacerbations. Antibiotics like telithromycin show promise for treating asthma, but more research is needed to confirm their effectiveness and safety.
Area of Science:
- Pulmonology
- Infectious Diseases
- Pharmacology
Background:
- Acute asthma exacerbations represent a significant unmet medical need.
- While viral infections are primary triggers, atypical bacterial infections are increasingly implicated in exacerbation severity and severe asthma.
- Macrolide and ketolide antibiotics possess activity against atypical bacteria and exhibit anti-inflammatory properties.
Purpose of the Study:
- To evaluate the efficacy of telithromycin, a ketolide antibiotic, in treating acute asthma exacerbations.
- To explore the potential role of atypical bacterial infections and antibiotic therapies in managing stable and severe asthma.
Main Methods:
- A recent study investigated the effectiveness of telithromycin in acute asthma exacerbations.
- Controlled studies have examined the impact of macrolide treatment on lung function in stable asthma.
Main Results:
- Telithromycin demonstrated effectiveness in treating acute asthma exacerbations, though its precise mechanism remains undetermined.
- Macrolide treatment in stable asthma yielded modest improvements in lung function.
Conclusions:
- Further controlled studies are essential to ascertain the role of macrolide and ketolide antibiotics in acute asthma exacerbations and severe stable asthma.
- The risk-benefit ratio for these therapies is most favorable in severe asthma cases where efficacy is established.
Related Concept Videos
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes: